Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975898324> ?p ?o ?g. }
- W1975898324 endingPage "215" @default.
- W1975898324 startingPage "204" @default.
- W1975898324 abstract "Choroidal neovascular membranes (CNVM) associated with pathological myopia (PM) can result in significant vision loss and legal blindness. These membranes usually occur subfoveally and are a major complication of PM, developing in approximately 5–10% of such eyes. PM is the second most common cause of choroidal neovascularization after age-related macular degeneration (AMD), and accounts for nearly 60% of CNVM cases in patients younger than age 50. Vascular endothelial growth factor-A has been implicated as the major angiogenic stimulus responsible for choroidal neovascularization secondary to AMD and several major studies have proved the benefits of anti-VEGF treatment for AMD-related CNVM. Benefits have also been observed in a number of prospective and retrospective studies evaluating PM CNVM. Despite the small differences in molecular properties of ranibizumab and bevacizumab, both drugs showed similar therapeutic effects for CNVM associated with PM. Many studies also highlighted that patient age, previous photodynamic therapy treatment, axial length, and visual acuity prior to treatment may affect treatment prognosis. Although there is a paucity of large randomized controlled trials, this systematic review highlights the large numbers of individual trials that demonstrate a significant improvement in VA. The inferior long-term results of alternative therapies, combined with an excellent safety profile from anti-VEGF treatment, make anti-VEGF the current recommended first-line therapy." @default.
- W1975898324 created "2016-06-24" @default.
- W1975898324 creator A5016588157 @default.
- W1975898324 creator A5070687891 @default.
- W1975898324 creator A5079213376 @default.
- W1975898324 creator A5084581613 @default.
- W1975898324 date "2015-05-01" @default.
- W1975898324 modified "2023-09-25" @default.
- W1975898324 title "The other CNVM: A review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents" @default.
- W1975898324 cites W110906275 @default.
- W1975898324 cites W115342157 @default.
- W1975898324 cites W1562343023 @default.
- W1975898324 cites W1976795673 @default.
- W1975898324 cites W1983392778 @default.
- W1975898324 cites W1988233478 @default.
- W1975898324 cites W1988457599 @default.
- W1975898324 cites W1991064811 @default.
- W1975898324 cites W1993266811 @default.
- W1975898324 cites W1995540454 @default.
- W1975898324 cites W1995708259 @default.
- W1975898324 cites W1999592084 @default.
- W1975898324 cites W1999809746 @default.
- W1975898324 cites W2001950796 @default.
- W1975898324 cites W2002972720 @default.
- W1975898324 cites W2004361001 @default.
- W1975898324 cites W2005450884 @default.
- W1975898324 cites W2012138315 @default.
- W1975898324 cites W2012710655 @default.
- W1975898324 cites W2012868839 @default.
- W1975898324 cites W2015446470 @default.
- W1975898324 cites W2017533242 @default.
- W1975898324 cites W2017670393 @default.
- W1975898324 cites W2022084143 @default.
- W1975898324 cites W2023526290 @default.
- W1975898324 cites W2023714093 @default.
- W1975898324 cites W2023874692 @default.
- W1975898324 cites W2025634016 @default.
- W1975898324 cites W2028741508 @default.
- W1975898324 cites W2031725950 @default.
- W1975898324 cites W2034029819 @default.
- W1975898324 cites W2036634700 @default.
- W1975898324 cites W2038513191 @default.
- W1975898324 cites W2047083844 @default.
- W1975898324 cites W2051258987 @default.
- W1975898324 cites W2051869883 @default.
- W1975898324 cites W2053648830 @default.
- W1975898324 cites W2055744370 @default.
- W1975898324 cites W2057953705 @default.
- W1975898324 cites W2060690838 @default.
- W1975898324 cites W2062886219 @default.
- W1975898324 cites W2063278513 @default.
- W1975898324 cites W2069895573 @default.
- W1975898324 cites W2072119754 @default.
- W1975898324 cites W2080591818 @default.
- W1975898324 cites W2080788600 @default.
- W1975898324 cites W2081727392 @default.
- W1975898324 cites W2082606620 @default.
- W1975898324 cites W2085295554 @default.
- W1975898324 cites W2087703104 @default.
- W1975898324 cites W2090557561 @default.
- W1975898324 cites W2091038445 @default.
- W1975898324 cites W2091407629 @default.
- W1975898324 cites W2091929661 @default.
- W1975898324 cites W2092226078 @default.
- W1975898324 cites W2095481572 @default.
- W1975898324 cites W2099999613 @default.
- W1975898324 cites W2103269419 @default.
- W1975898324 cites W2107751384 @default.
- W1975898324 cites W2115153828 @default.
- W1975898324 cites W2116554707 @default.
- W1975898324 cites W2138421229 @default.
- W1975898324 cites W2139891060 @default.
- W1975898324 cites W2141545090 @default.
- W1975898324 cites W2142405257 @default.
- W1975898324 cites W2155905635 @default.
- W1975898324 cites W2314715930 @default.
- W1975898324 cites W2321481116 @default.
- W1975898324 cites W233579014 @default.
- W1975898324 cites W2410906612 @default.
- W1975898324 cites W2518511344 @default.
- W1975898324 cites W2581767635 @default.
- W1975898324 cites W2615507930 @default.
- W1975898324 cites W2748001554 @default.
- W1975898324 cites W4233657213 @default.
- W1975898324 cites W4240897419 @default.
- W1975898324 cites W4252273760 @default.
- W1975898324 cites W4255271122 @default.
- W1975898324 cites W4361866471 @default.
- W1975898324 doi "https://doi.org/10.1016/j.survophthal.2014.10.002" @default.
- W1975898324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25890624" @default.
- W1975898324 hasPublicationYear "2015" @default.
- W1975898324 type Work @default.
- W1975898324 sameAs 1975898324 @default.
- W1975898324 citedByCount "19" @default.
- W1975898324 countsByYear W19758983242016 @default.
- W1975898324 countsByYear W19758983242017 @default.
- W1975898324 countsByYear W19758983242018 @default.
- W1975898324 countsByYear W19758983242019 @default.